CN100463690C - Chinese medicine tea bag - Google Patents
Chinese medicine tea bag Download PDFInfo
- Publication number
- CN100463690C CN100463690C CNB200510061745XA CN200510061745A CN100463690C CN 100463690 C CN100463690 C CN 100463690C CN B200510061745X A CNB200510061745X A CN B200510061745XA CN 200510061745 A CN200510061745 A CN 200510061745A CN 100463690 C CN100463690 C CN 100463690C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- tea
- radix
- medicine bag
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 18
- 241001122767 Theaceae Species 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 22
- 235000009569 green tea Nutrition 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 4
- 241000628997 Flos Species 0.000 claims description 14
- 235000013616 tea Nutrition 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 238000007603 infrared drying Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 abstract description 8
- 238000002360 preparation method Methods 0.000 abstract description 3
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 240000005979 Hordeum vulgare Species 0.000 abstract 1
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract 1
- 241000735234 Ligustrum Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 241000731475 Trachycarpus Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 208000024172 Cardiovascular disease Diseases 0.000 description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052683 pyrite Inorganic materials 0.000 description 3
- 239000011028 pyrite Substances 0.000 description 3
- RIXNFYQZWDGQAE-DFHVBEEKSA-N (4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-acetyloxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound C([C@H]1C2=CC[C@H]34)C(C)(C)CC[C@]1(C(O)=O)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)C)C1(C)C RIXNFYQZWDGQAE-DFHVBEEKSA-N 0.000 description 2
- PHFUCJXOLZAQNH-OTMOLZNZSA-N Acetylursolic acid Chemical compound C1C[C@H](OC(C)=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PHFUCJXOLZAQNH-OTMOLZNZSA-N 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- KUBCEEMXQZUPDQ-UHFFFAOYSA-N hordenine Chemical compound CN(C)CCC1=CC=C(O)C=C1 KUBCEEMXQZUPDQ-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- STKUCSFEBXPTAY-KCWGXYKVSA-N nuezhenoside Natural products COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(=CC)[C@@H]1CC(=O)OC[C@H]1O[C@@H](OCCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O STKUCSFEBXPTAY-KCWGXYKVSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 2
- -1 pyrite glycoside Chemical class 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- WEHXAEGTVPWKDY-UHFFFAOYSA-N toralactone Chemical compound C1=C(C)OC(=O)C=2C1=CC1=CC(OC)=CC(O)=C1C=2O WEHXAEGTVPWKDY-UHFFFAOYSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NULBHTHMVOCGOE-ZBCCAYPVSA-N 7-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@H](OC=2C=C3C(C(C=C(O3)C=3C=CC(O)=CC=3)=O)=C(O)C=2)O1 NULBHTHMVOCGOE-ZBCCAYPVSA-N 0.000 description 1
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 206010065558 Aortic arteriosclerosis Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- CBOKHFLBNZMMAA-UHFFFAOYSA-N Emodin anthrone Natural products OC1=CC(O)=CC2=CC3=CC(C)=CC(O)=C3C(O)=C21 CBOKHFLBNZMMAA-UHFFFAOYSA-N 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000019468 Iatrogenic Disease Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- MZSGWZGPESCJAN-MOBFUUNNSA-N Melitric acid A Natural products O([C@@H](C(=O)O)Cc1cc(O)c(O)cc1)C(=O)/C=C/c1cc(O)c(O/C(/C(=O)O)=C/c2cc(O)c(O)cc2)cc1 MZSGWZGPESCJAN-MOBFUUNNSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- CFLNHFUPWNRWJA-UHFFFAOYSA-N Obtusin Chemical group O=C1C2=CC(C)=C(O)C(OC)=C2C(=O)C2=C1C=C(OC)C(OC)=C2O CFLNHFUPWNRWJA-UHFFFAOYSA-N 0.000 description 1
- OBBJQZSMXOJMCN-UHFFFAOYSA-N Obtusin Natural products COc1cc2C=CC(=O)Oc2c3OCC(Oc13)C(=C)C OBBJQZSMXOJMCN-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical compound O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- 208000001792 Sarcoma 37 Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 1
- 241000218636 Thuja Species 0.000 description 1
- PHFUCJXOLZAQNH-UHFFFAOYSA-N Ursolic acid acetat Natural products C1CC(OC(C)=O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)C(C)C5C4=CCC3C21C PHFUCJXOLZAQNH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 201000001962 aortic atherosclerosis Diseases 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- LAJSXCAVRQXZIO-UHFFFAOYSA-N emodin anthrone Chemical compound C1=C(O)C=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O LAJSXCAVRQXZIO-UHFFFAOYSA-N 0.000 description 1
- SBHXYTNGIZCORC-ZDUSSCGKSA-N eriodictyol Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-ZDUSSCGKSA-N 0.000 description 1
- TUJPOVKMHCLXEL-UHFFFAOYSA-N eriodictyol Natural products C1C(=O)C2=CC(O)=CC(O)=C2OC1C1=CC=C(O)C(O)=C1 TUJPOVKMHCLXEL-UHFFFAOYSA-N 0.000 description 1
- 235000011797 eriodictyol Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- SBHXYTNGIZCORC-UHFFFAOYSA-N eriodyctiol Natural products O1C2=CC(O)=CC(O)=C2C(=O)CC1C1=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229940071490 hordenine Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 235000011576 oleuropein Nutrition 0.000 description 1
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 1
- 229940026509 theaflavin Drugs 0.000 description 1
- 235000008118 thearubigins Nutrition 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicine the bag for obviously improving and preventing the diseases of hypertension, hyperlipemia and angiocardiopathy. It is made up by using 8 Chinese medicinal materials of fetid cassia seed, trachycarpus flower, sophora flower, ligustrum fruit, rhubarb, fresh barley sprout, green tea and licorice through a certain preparation process. Said invention also provides the concrete steps of said preparation method.
Description
Technical field
The present invention relates to a kind of Chinese medicine bag and make tea, especially relate to a kind ofly to hypertension, hyperlipidemia, and cardiovascular disease has clear improvement and the teabag of preventive effect.
Background technology
Along with social progress, the raising of economic level, cardiovascular disease has become " the No.1 killer " who threatens human life and health, the occurrence cause of cardiovascular and cerebrovascular disease mainly is a hypertension, hyperlipidemia, the patient is because take treatment cardiovascular disease or hypertension for a long time, the medicine of hyperlipidemia chronic diseases, how can produce the drug resistance reaction, drug allergy, or even lead to some iatrogenic diseases, and it is lighter for the state of an illness, sick duration, the patient who is difficult to fully recover for the moment, life-time service chemical drugs or antibiotics medicine, side effect is more obvious with respect to curative effect, therefore, people except adhering to Drug therapy, more and more take to drink targetedly medicated tea as auxiliary treatment means for this class chronic disease, good auxiliary treatment effect can be played on the one hand, the effect of health care can be played on the other hand.
Summary of the invention
The present invention mainly provides a kind of to hypertension, hyperlipidemia, and cardiovascular disease has clear improvement and the Chinese medicine bag of preventive effect is made tea.
Above-mentioned purpose of the present invention mainly is achieved by following technical proposals: Chinese medicine bag is made tea, form by following compositions in weight percentage---Semen Cassiae 10%～25%, Flos Trachycarpi 8%～25%, the Flos Sophorae Immaturus 5%～20%, Fructus Ligustri Lucidi 1%～15%, Radix Et Rhizoma Rhei 7%～25%, Fructus Hordei Germinatus 3%～20%, green tea 1%～10%, Radix Glycyrrhizae 5%～20%, each component summation is 100%.The procedure of processing that obtains described teabag finished product is: (1) selected each component raw material, guarantee the quality cleaning, and water content is lower than 5%; (2) each component material is mixed in proportion after, be crushed to the about 5～50mm of granularity; (3) be crushed to the about 0.1～5mm of granularity again, carry out fineness thereafter and pulverize the about 0.1mm of final size; (4) infrared drying, sterilization; (5) weighing, packing, envelope get final product.Because medicine is crushed to microgranule, its surface area is when decocting, also increase with the contact area of water thereupon, the easy stripping of effective ingredient, boiling water brews when drinking, and is container with the teacup, because of good heat insulating, usually can make water temperature in a period of time, maintain 80 ℃～95 ℃, can guarantee the abundant stripping of effective ingredient and don't destroyed like this.
As preferably, the weight proportion of described each component preferably: Semen Cassiae 20%, Flos Trachycarpi 20%, the Flos Sophorae Immaturus 15%, Fructus Ligustri Lucidi 5%, Radix Et Rhizoma Rhei 15%, Fructus Hordei Germinatus 10%, green tea 5%, Radix Glycyrrhizae 10%, each component summation is 100%.
Each component property of medicine pharmacology during Chinese medicine bag of the present invention is made tea and filled a prescription:
A: Semen Cassiae---sweet, bitter, be slightly cold, go into Liver Channel, main component is obtusin, toralactone, vitamin A, chrysophanol, emodin, chrysophanic acid, emodin anthrone, the effect of liver heat removing and eyesight improving, blood pressure lowering and reduction serum cholesterol is arranged, and can restrain the formation of atherosclerosis of aorta speckle, therefore sclerosis has remarkable result with hypertension to treatment of vascular;
B: Flos Trachycarpi---puckery, cool in nature, return liver, spleen channel, dampness detoxifcation, astringing to arrest bleeding.
C: the Flos Sophorae Immaturus---bitter in the mouth, cold are trembled with fear into conscience intestinal four warps, because rutin pyrite salidroside content is up to 21.0% in the Flos Sophorae Immaturus tea, the pyrite glycoside can promote the blood capillary circulation, keep the normal resistance of blood capillary, reduce the permeability of blood vessel, energy vessel softening, blood pressure lowering, increase blood vessel elasticity can make because of fragility increases hemorrhage blood capillary and recover normal elasticity, so can also effectively reduce cholesterol level in liver, aorta and the blood; In addition aspect the cardiovascular effect, but contained pyrite glycoside, Quercetin expanding coronary artery in the Flos Sophorae Immaturus, microcirculation improvement, many pyrite derivatives of synthetic at present, expanding coronary artery and arrhythmia are arranged, and its preparation has the microcirculation of promotion, blood fat-reducing blood pressure-decreasing effect more;
D: Fructus Ligustri Lucidi---contain nuezhenoside, 10-hydroxyl nuezhenoside, oleuropein, Quercetin, raceme eriodictyol, oleanolic acid, acetyloleanolic acid, ursolic acid, acetyl ursolic acid, Fructus Ligustri Lucidi acid, Fructus Ligustri Lucidi thuja acid, cupreol etc.; Pharmacological research shows, Fructus Ligustri Lucidi have antiinflammatory and promote immunologic function effect---the mice auricle swelling that Fructus Ligustri Lucidi water decoction xylol causes, the mouse peritoneal capillary permeability increase that acetic acid causes and carrageenin, Ovum Gallus domesticus album, formaldehyde rat paw edema all have obvious inhibitory action.Immune Effects is shown that then its water decoction continuous irrigation stomach can make mouse thymus childhood, spleen weight obviously increase;
E: Radix Et Rhizoma Rhei---property of medicine hardship, cold is returned spleen, stomach, large intestine, liver, gallbladder meridian, contains anthraquinone classes about 30% such as chrysophanol, chrysophanic acid, aloe-emodin, tannin about 5%, pharmacological testing shows, uses the crude extract of Radix Et Rhizoma Rhei to carry out subcutaneous injection, and murine sarcoma-37 is had direct injury ability; Emodin and chrysophanic acid all have the obvious suppression effect to murine melanoma, lymphosarcoma, breast carcinoma and ehrlich carcinoma; To the direct destruction of cancerous cell, can make blood pressure drops, the oral effect that reduction serum hypercholesterolemia is arranged of immersion; That the traditional Chinese medical science is used for relieving internal heat more is anticancer, purge heat and lead long-pending, detumescence by becoming silted up;
F: Fructus Hordei Germinatus---main starch-containing enzyme, conversion carbohydrase, oxidase, catalyzing enzyme, cellobiase, gentiobiase, hordenine are approximately, lecithin, aminoacid, and cytochrome C, for cholesterol dissolution is arranged, but blood pressure lowering, also have simultaneously refresh oneself, effect such as spleen invigorating, appetizing;
G: the flavonol in the green tea is the main ingredient of treatment coronary heart disease, thearubigins and theaflavin, can suppress angiotonic activity (angiotensin is the principal element that causes under present most of hyperpietic's hypertension not) effectively, caffeine in the green tea and catechin also have the loose blood vessel wall that makes of the blood vessel wall of making and keep enough elasticity, increase the effect of blood vessel effective diameter, because green tea has anticoagulant, short molten, suppress hematoblastic accumulation, blood fat reducing, increase a lipoprotein, improve the cholesterol in the blood and the effects such as ratio of phospholipid, can reduce speckle on arteries and the arteria coronaria inwall formation, reach and improve and arteriosclerosis, blood circulation promoting and blood stasis dispelling, prevent and treat the purpose of cardiovascular disease.
Therefore, the present invention is the property of thing of getting it filled, the flavor of drinking tea, both compatibilities complement each other, and have prescription rationally, easy row simple for production, the stripping quantity of effective ingredient is big, is easily drawn by body after taking, act on advantages such as rapid, this Chinese medicine bag of long-term drink is made tea, can stabilizing blood pressure, improve cerebral blood flow, the generation of prevention of stroke has prevention, auxiliary treatment to hypertension, hyperlipidemia and cardiovascular patient, and human body had tonic effect, drink conveniently.
The specific embodiment
Below by embodiment, technical scheme of the present invention is described in further detail.
Embodiment: making tea with every production 100Kg Chinese medicine bag is example---selected Semen Cassiae 20Kg, Flos Trachycarpi 20Kg, Flos Sophorae Immaturus 15Kg, Fructus Ligustri Lucidi 5Kg, Radix Et Rhizoma Rhei 15Kg, Fructus Hordei Germinatus 10Kg, green tea 5Kg, Radix Glycyrrhizae 10Kg, guarantee each component quality cleaning, water content is lower than 5%; Behind each component material uniform mixing, be crushed to the about 5～50mm of granularity; Carry out the second time and pulverize, to granularity between 0.1～5mm, carry out fineness thereafter and pulverize the about 0.1mm of final size; Carry out infrared drying, sterilization; Weighing, packing, envelope get final product.
At last, should be pointed out that above embodiment only is the more representational example of the present invention.Obviously, technical scheme of the present invention is not limited to the foregoing description, and many distortion can also be arranged.All distortion that those of ordinary skill in the art can directly derive or associate from content disclosed by the invention all should be thought protection scope of the present invention.
Claims (3)
1. a Chinese medicine bag is made tea, and it is characterized in that being made up of following compositions in weight percentage: Semen Cassiae 10%～25%, Flos Trachycarpi 8%～25%, the Flos Sophorae Immaturus 5%～20%, Fructus Ligustri Lucidi 1%～15%, Radix Et Rhizoma Rhei 7%～25%, Fructus Hordei Germinatus 3%～20%, green tea 1%～10%, Radix Glycyrrhizae 5%～20%, each component summation are 100%.
2. Chinese medicine bag according to claim 1 is made tea, and it is characterized in that each weight percentages of components composition: Semen Cassiae 20%, Flos Trachycarpi 20%, the Flos Sophorae Immaturus 15%, Fructus Ligustri Lucidi 5%, Radix Et Rhizoma Rhei 15%, Fructus Hordei Germinatus 10%, green tea 5%, Radix Glycyrrhizae 10%, each component summation are 100%.
3. Chinese medicine bag according to claim 1 is made tea, and it is characterized in that the procedure of processing that obtains described teabag finished product is:
(1) selected each component raw material guarantees the quality cleaning, and water content is lower than 5%;
(2) each component material is mixed in proportion after, being crushed to granularity is 5～50mm;
(3) being crushed to granularity again is 0.1～5mm, carries out fineness thereafter and pulverizes, and final size is 0.1mm;
(4) infrared drying, sterilization;
(5) weighing, packing, sealing get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510061745XA CN100463690C (en) | 2005-11-30 | 2005-11-30 | Chinese medicine tea bag |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510061745XA CN100463690C (en) | 2005-11-30 | 2005-11-30 | Chinese medicine tea bag |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1977954A CN1977954A (en) | 2007-06-13 |
| CN100463690C true CN100463690C (en) | 2009-02-25 |
Family
ID=38129374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200510061745XA Expired - Fee Related CN100463690C (en) | 2005-11-30 | 2005-11-30 | Chinese medicine tea bag |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100463690C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105166146A (en) * | 2015-09-14 | 2015-12-23 | 贵州大自然科技股份有限公司 | Trachycarpus fortunei polyphenolblack tea and preparation method thereof |
| CN105145940A (en) * | 2015-09-14 | 2015-12-16 | 贵州大自然科技股份有限公司 | Palm polyphenol green tea and preparation method thereof |
| CN105166179A (en) * | 2015-09-14 | 2015-12-23 | 贵州大自然科技股份有限公司 | Trachycarpus fortunei flower flavored black tea and preparation method thereof |
| CN106954702A (en) * | 2016-01-12 | 2017-07-18 | 蔡德成 | A kind of maidenhair tea bag with health role and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1478508A (en) * | 2002-12-31 | 2004-03-03 | 临沂新时代药业有限公司 | Chinese medicinal composition for treating fatty liver and its preparation method |
-
2005
- 2005-11-30 CN CNB200510061745XA patent/CN100463690C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1478508A (en) * | 2002-12-31 | 2004-03-03 | 临沂新时代药业有限公司 | Chinese medicinal composition for treating fatty liver and its preparation method |
Non-Patent Citations (2)
| Title |
|---|
| 国内降血脂中草药研究概况. 彭悦.中国中药杂志，第8卷第1期. 1983 |
| 国内降血脂中草药研究概况. 彭悦.中国中药杂志，第8卷第1期. 1983 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1977954A (en) | 2007-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103861060B (en) | Sobering-up tablet and preparation method thereof | |
| CN1954686B (en) | Tea beverage for reducing blood fat and its preparation method | |
| WO2010054520A1 (en) | Pharmaceutical composition for purifing vein and preparation method thereof | |
| CN101543248B (en) | A cold tea especially suitable for 'three high and one acid' population and method for preparing same | |
| CN100463690C (en) | Chinese medicine tea bag | |
| CN103891962A (en) | Health tea capable of beautifying face and losing weight and preparation method of health tea | |
| CN102600358A (en) | Traditional Chinese laxative medicine and product thereof | |
| CN107494817A (en) | A kind of hypoglycemic tea | |
| CN106390077A (en) | Pharmaceutical composition for treating stomachache and diarrhea and preparation method and application thereof | |
| KR20160014075A (en) | Cynanchi Wilfordii Tea and Manufacture Method thereof | |
| CN105833011A (en) | Healthcare medicinal liquor | |
| CN102462787B (en) | Chinese medicine composition for treating hypertension and improving hyperlipidemia and preparation method of Chinese medicine composition | |
| CN109260320A (en) | A kind of composition and purposes of tea polyphenols and Chinese medical extract | |
| CN104146302A (en) | Blueberry juice drink | |
| CN104187979A (en) | Cucumis melo var. saccharinus drink | |
| CN103960415A (en) | Weight-losing health herbal tea and preparation method thereof | |
| CN1434717A (en) | Medicine for treating obesity and method of producing and use thereof | |
| KR20130102181A (en) | A tea using cyperus rotundus and method thereof | |
| CN105724694A (en) | Whitening and freckle-removing herbal tea | |
| CN100355434C (en) | Medicine for preventing and treating cardiovascular and cerebrovascular diseases | |
| CN104543221A (en) | Tea with functions of relaxing muscles and tendons, and preparation method of tea | |
| CN109331089A (en) | Composition and purposes rich in tea polyphenols Chinese medical extract | |
| CN103860948A (en) | Traditional Chinese medicine for treating acute mastitis caused by qi stagnation and heat congestion and preparation method thereof | |
| CN106819252A (en) | Reducing blood lipid beauty tea and preparation method thereof | |
| CN114767794B (en) | Traditional Chinese medicine for treating arterial plaque |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090225 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |